Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-thyroid drug regimens in children and adolescents with thyrotoxicosis
ISRCTN82088322Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of carbimazole, propylthiouracil and levothyroxine sodium in thyrotoxicosis (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Biochemical control based on TSH. Started Jan 2005; status: completed.
02
Drugs
carbimazolepropylthiouracillevothyroxine sodium
03
Conditions
thyrotoxicosis
Beyond the preview
Go deeper on ISRCTN82088322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN82088322.